Marine Drugs and Natural Products

Biography

Hafiz Ahmed is founder, President and Chief Scientific Officer of GlycoMantra Inc., Baltimore, USA. After receiving his PhD from the Indian Association for the Cultivation of Science (Kolkata, India), he worked as a Post-doc fellow at the Max Planck Institute (Gottingen, Germany), as a Research Associate at the Roswell Park Cancer Institute (Buffalo, USA) and then as a faculty at the University of Maryland (Baltimore, USA). He has extensive expertise in glyco-biology and protein chemistry and over 25 years of research experience in structure-function studies of lectins, particularly on galectins. He published over 100 research articles in peer-reviewed journals including Proceedings of the National Academy of Sciences, Biomaterials, Journal of Immunology; Journal of Biological Chemistry, Breast Cancer Research Treatment, and Glycobiology. He authored a book on protein chemistry (CRC Press), co-edited a book on animal lectins (Taylor & Francis) and edited a special issue “Glycobiology of Cancer” for the Frontiers in Bioscience. He secured several federal and state grants funding of over 4 Million dollars. He is a lead inventor of 5 US patents (awarded and pending). He is a reviewer of many reputed journals, editor of 4 journals and currently serving as Editor-in-Chief of Glycobiology Insights.

Abstract

Abstract : Cod glycopeptides suppresses T-cell apoptosis and prostate cancer metastasis